Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Troendle August J.. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Troendle August J. har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:MEDP / Medpace Holdings, Inc. | CEO, Director, 10% Owner | 924 602 |
US:CHRS / Coherus Oncology, Inc. | Director | 20 000 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Troendle August J.. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp CHRS / Coherus Oncology, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i CHRS / Coherus Oncology, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i CHRS / Coherus Oncology, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderköp MEDP / Medpace Holdings, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i CHRS / Coherus Oncology, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i CHRS / Coherus Oncology, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Troendle August J. som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-09-03 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −1 197 | 924 602 | −0,13 | 475,11 | −568 707 | 439 287 656 | |
2025-09-03 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −36 196 | 925 799 | −3,76 | 475,90 | −17 225 676 | 440 587 744 | |
2025-08-28 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −620 | 961 995 | −0,06 | 475,00 | −294 500 | 456 947 625 | |
2025-07-29 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −48 487 | 962 615 | −4,80 | 451,69 | −21 901 093 | 434 803 569 | |
2025-03-10 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
M - Exercise | 84 770 | 1 011 102 | 9,15 | 107,93 | 9 149 226 | 109 128 239 | |
2025-03-10 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
M - Exercise | 234 259 | 926 332 | 33,85 | 56,61 | 13 261 402 | 52 439 655 | |
2025-03-10 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
M - Exercise | 37 417 | 692 073 | 5,72 | 54,74 | 2 048 207 | 37 884 076 | |
2024-05-29 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −5 695 | 654 656 | −0,86 | 395,49 | −2 252 316 | 258 909 901 | |
2024-05-29 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −3 987 | 660 351 | −0,60 | 395,22 | −1 575 742 | 260 983 922 | |
2024-05-24 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −55 | 664 338 | −0,01 | 400,00 | −22 000 | 265 735 200 | |
2024-05-22 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −4 020 | 664 393 | −0,60 | 400,19 | −1 608 764 | 265 883 435 | |
2024-05-17 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −7 060 | 668 413 | −1,05 | 403,09 | −2 845 815 | 269 430 596 | |
2024-05-17 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −32 282 | 675 473 | −4,56 | 405,13 | −13 078 407 | 273 654 376 | |
2024-05-14 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −4 956 | 707 755 | −0,70 | 402,89 | −1 996 723 | 285 147 412 | |
2024-05-10 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −3 486 | 712 711 | −0,49 | 400,17 | −1 394 993 | 285 205 561 | |
2024-05-10 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −4 782 | 716 197 | −0,66 | 400,58 | −1 915 574 | 286 894 194 | |
2024-05-08 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −28 032 | 720 979 | −3,74 | 404,48 | −11 338 383 | 291 621 586 | |
2024-05-08 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −24 372 | 749 011 | −3,15 | 401,73 | −9 790 964 | 300 900 189 | |
2024-05-03 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −3 396 | 773 383 | −0,44 | 400,44 | −1 359 894 | 309 693 489 | |
2024-05-03 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −12 934 | 776 779 | −1,64 | 401,56 | −5 193 777 | 311 923 375 | |
2024-05-01 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −1 828 | 789 713 | −0,23 | 400,31 | −731 767 | 316 130 011 | |
2024-05-01 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −15 102 | 791 541 | −1,87 | 400,69 | −6 051 220 | 317 162 563 | |
2024-03-08 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −25 000 | 4 733 019 | −0,53 | 408,71 | −10 217 750 | 1 934 432 195 | |
2024-03-08 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −75 000 | 4 758 019 | −1,55 | 410,74 | −30 805 500 | 1 954 308 724 | |
2024-03-08 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −100 000 | 4 833 019 | −2,03 | 412,98 | −41 298 000 | 1 995 940 187 | |
2024-03-06 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −50 000 | 4 933 019 | −1,00 | 402,70 | −20 135 000 | 1 986 526 751 | |
2024-03-06 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −50 000 | 4 983 019 | −0,99 | 403,12 | −20 156 000 | 2 008 754 619 | |
2024-03-04 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −80 000 | 5 033 019 | −1,56 | 401,88 | −32 150 400 | 2 022 669 676 | |
2024-03-04 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −20 000 | 5 113 019 | −0,39 | 393,71 | −7 874 200 | 2 013 046 710 | |
2024-02-29 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −50 000 | 5 133 019 | −0,96 | 404,13 | −20 206 500 | 2 074 406 968 | |
2024-02-29 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −50 000 | 5 183 019 | −0,96 | 401,88 | −20 094 000 | 2 082 951 676 | |
2024-02-27 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −56 928 | 5 233 019 | −1,08 | 402,38 | −22 906 689 | 2 105 662 185 | |
2024-02-27 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −100 000 | 5 289 947 | −1,86 | 400,32 | −40 032 000 | 2 117 671 583 | |
2024-02-23 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −100 000 | 5 389 947 | −1,82 | 395,98 | −39 598 000 | 2 134 311 213 | |
2024-02-23 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −36 012 | 5 489 947 | −0,65 | 383,44 | −13 808 441 | 2 105 065 278 | |
2024-02-21 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −13 988 | 5 525 959 | −0,25 | 386,39 | −5 404 823 | 2 135 175 298 | |
2024-02-21 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −50 000 | 5 539 947 | −0,89 | 391,75 | −19 587 500 | 2 170 274 237 | |
2023-12-01 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −24 039 | 5 589 947 | −0,43 | 273,26 | −6 568 897 | 1 527 508 917 | |
2023-12-01 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −7 871 | 5 613 986 | −0,14 | 272,18 | −2 142 329 | 1 528 014 709 | |
2023-12-01 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −18 090 | 5 621 857 | −0,32 | 272,62 | −4 931 696 | 1 532 630 655 | |
2023-12-01 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −3 167 | 5 639 947 | −0,06 | 272,87 | −864 179 | 1 538 972 338 | |
2023-11-29 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −21 833 | 5 643 114 | −0,39 | 273,66 | −5 974 819 | 1 544 294 577 | |
2023-11-29 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −25 000 | 5 664 947 | −0,44 | 276,10 | −6 902 500 | 1 564 091 867 | |
2023-11-27 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −25 000 | 5 689 947 | −0,44 | 277,81 | −6 945 250 | 1 580 724 176 | |
2023-11-22 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −25 000 | 5 714 947 | −0,44 | 277,37 | −6 934 250 | 1 585 154 849 | |
2023-11-21 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −50 000 | 5 739 947 | −0,86 | 275,45 | −13 772 500 | 1 581 068 401 | |
2023-11-21 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −50 000 | 5 789 947 | −0,86 | 273,91 | −13 695 500 | 1 585 924 383 | |
2023-11-16 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −17 000 | 5 839 947 | −0,29 | 281,61 | −4 787 370 | 1 644 587 475 | |
2023-11-16 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −33 000 | 5 856 947 | −0,56 | 283,42 | −9 352 860 | 1 659 975 919 | |
2023-11-16 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | −25 000 | 5 889 947 | −0,42 | 283,11 | −7 077 750 | 1 667 502 895 | |
2023-09-21 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −61 655 | 5 914 947 | −1,03 | 244,27 | −15 060 467 | 1 444 844 104 |
2023-09-21 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −65 653 | 5 976 602 | −1,09 | 255,48 | −16 773 028 | 1 526 902 279 |
2023-09-20 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −137 379 | 6 042 255 | −2,22 | 259,66 | −35 671 831 | 1 568 931 933 |
2023-09-20 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −53 385 | 6 179 634 | −0,86 | 274,76 | −14 668 063 | 1 697 916 238 |
2023-06-12 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −49 347 | 6 233 019 | −0,79 | 220,85 | −10 898 285 | 1 376 562 246 |
2023-06-08 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −110 324 | 6 282 366 | −1,73 | 223,05 | −24 607 768 | 1 401 281 736 |
2023-06-08 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −58 681 | 6 392 690 | −0,91 | 220,46 | −12 936 813 | 1 409 332 437 |
2023-04-27 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −31 648 | 6 451 371 | −0,49 | 221,83 | −7 020 476 | 1 431 107 629 |
2022-09-23 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
P - Purchase | X | 57 426 | 6 483 019 | 0,89 | 154,59 | 8 877 485 | 1 002 209 907 |
2022-09-22 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
P - Purchase | X | 94 119 | 6 425 593 | 1,49 | 161,63 | 15 212 454 | 1 038 568 597 |
2022-09-22 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
P - Purchase | X | 94 119 | 6 331 474 | 1,51 | 155,14 | 14 601 622 | 982 264 876 |
2022-09-20 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
P - Purchase | X | 94 119 | 6 237 355 | 1,53 | 153,48 | 14 445 384 | 957 309 245 |
2022-09-20 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
P - Purchase | X | 62 516 | 6 143 236 | 1,03 | 149,58 | 9 351 143 | 918 905 241 |
2022-09-16 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
P - Purchase | X | 62 516 | 6 080 720 | 1,04 | 153,11 | 9 571 825 | 931 019 039 |
2022-09-16 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
P - Purchase | X | 62 516 | 6 018 204 | 1,05 | 152,66 | 9 543 693 | 918 739 023 |
2022-09-14 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
P - Purchase | X | 62 516 | 5 955 688 | 1,06 | 157,12 | 9 822 514 | 935 757 699 |
2022-09-14 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
P - Purchase | X | 62 515 | 5 893 172 | 1,07 | 167,58 | 10 476 264 | 987 577 764 |
2022-09-12 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
P - Purchase | X | 56 557 | 5 830 657 | 0,98 | 164,33 | 9 294 012 | 958 151 865 |
2022-09-12 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
P - Purchase | X | 56 557 | 5 774 100 | 0,99 | 157,65 | 8 916 211 | 910 286 865 |
2022-09-08 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
P - Purchase | X | 56 557 | 5 717 543 | 1,00 | 150,72 | 8 524 271 | 861 748 081 |
2022-09-08 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
P - Purchase | X | 56 557 | 5 660 986 | 1,01 | 147,59 | 8 347 248 | 835 504 924 |
2022-09-06 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
P - Purchase | X | 48 714 | 5 604 429 | 0,88 | 144,98 | 7 062 556 | 812 530 116 |
2022-09-06 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
P - Purchase | X | 42 076 | 5 555 715 | 0,76 | 144,52 | 6 080 824 | 802 911 932 |
2022-07-20 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
P - Purchase | X | 8 330 | 5 513 639 | 0,15 | 145,00 | 1 207 850 | 799 477 655 |
2022-07-18 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
P - Purchase | X | 22 290 | 5 505 309 | 0,41 | 144,59 | 3 222 911 | 796 012 628 |
2022-03-03 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −100 000 | 0 | −100,00 | ||||
2022-03-03 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
M - Exercise | 100 000 | 806 643 | 14,15 | 90,65 | 9 065 000 | 73 122 188 | |
2022-02-17 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 93 174 | 93 174 | |||||
2022-01-06 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −3 338 | 5 483 019 | −0,06 | 213,44 | −712 463 | 1 170 295 575 |
2022-01-04 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −19 744 | 5 486 357 | −0,36 | 212,70 | −4 199 549 | 1 166 948 134 |
2022-01-04 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −13 069 | 5 506 101 | −0,24 | 219,14 | −2 863 941 | 1 206 606 973 |
2022-01-04 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −17 376 | 5 519 170 | −0,31 | 220,34 | −3 828 628 | 1 216 093 918 |
2021-12-30 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −16 750 | 5 536 546 | −0,30 | 220,16 | −3 687 680 | 1 218 925 967 |
2021-12-30 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −24 118 | 5 553 296 | −0,43 | 222,18 | −5 358 537 | 1 233 831 305 |
2021-12-28 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −39 171 | 5 577 414 | −0,70 | 226,11 | −8 856 955 | 1 261 109 080 |
2021-12-28 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −22 830 | 5 616 585 | −0,40 | 223,19 | −5 095 428 | 1 253 565 606 |
2021-12-23 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −38 960 | 5 639 415 | −0,69 | 220,50 | −8 590 680 | 1 243 491 008 |
2021-12-23 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −18 133 | 5 678 375 | −0,32 | 215,17 | −3 901 678 | 1 221 815 949 |
2021-12-21 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −22 734 | 5 696 508 | −0,40 | 212,57 | −4 832 566 | 1 210 906 706 |
2021-12-21 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −30 605 | 5 719 242 | −0,53 | 213,59 | −6 536 922 | 1 221 572 899 |
2021-12-17 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −5 959 | 5 749 847 | −0,10 | 210,22 | −1 252 701 | 1 208 732 836 |
2021-12-17 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −2 424 | 5 755 806 | −0,04 | 210,28 | −509 719 | 1 210 330 886 |
2021-12-13 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −309 | 5 758 230 | −0,01 | 210,20 | −64 952 | 1 210 379 946 |
2021-12-13 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −14 994 | 5 758 539 | −0,26 | 212,13 | −3 180 677 | 1 221 558 878 |
2021-12-09 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −15 871 | 5 773 533 | −0,27 | 212,89 | −3 378 777 | 1 229 127 440 |
2021-12-09 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −18 520 | 5 789 404 | −0,32 | 211,78 | −3 922 166 | 1 226 079 979 |
2021-12-07 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −400 | 5 807 924 | −0,01 | 211,48 | −84 592 | 1 228 259 768 |
2021-12-03 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −6 090 | 5 808 324 | −0,10 | 210,79 | −1 283 711 | 1 224 336 616 |
2021-12-03 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −26 642 | 5 814 414 | −0,46 | 211,57 | −5 636 648 | 1 230 155 570 |
2021-12-01 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −197 | 5 841 056 | 0,00 | 210,29 | −41 427 | 1 228 315 666 |
2021-12-01 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −12 115 | 5 841 253 | −0,21 | 212,10 | −2 569 592 | 1 238 929 761 |
2021-11-29 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −15 071 | 5 853 368 | −0,26 | 210,99 | −3 179 830 | 1 235 002 114 |
2021-11-29 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −14 578 | 5 868 439 | −0,25 | 213,26 | −3 108 904 | 1 251 503 301 |
2021-11-24 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −26 057 | 5 883 017 | −0,44 | 212,64 | −5 540 760 | 1 250 964 735 |
2021-11-24 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −48 128 | 5 909 074 | −0,81 | 224,33 | −10 796 554 | 1 325 582 570 |
2021-09-07 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −604 | 5 957 202 | −0,01 | 191,82 | −115 859 | 1 142 710 488 |
2021-09-07 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −30 234 | 5 957 806 | −0,50 | 191,85 | −5 800 393 | 1 143 005 081 |
2021-09-02 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −14 304 | 5 988 040 | −0,24 | 186,29 | −2 664 692 | 1 115 511 972 |
2021-09-02 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −12 675 | 6 002 344 | −0,21 | 182,04 | −2 307 357 | 1 092 666 702 |
2021-08-31 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −12 236 | 6 015 019 | −0,20 | 183,14 | −2 240 901 | 1 101 590 580 |
2021-08-31 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −11 840 | 6 027 255 | −0,20 | 181,83 | −2 152 867 | 1 095 935 777 |
2021-08-27 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −466 | 6 039 095 | −0,01 | 180,17 | −83 959 | 1 088 063 746 |
2021-08-27 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −7 622 | 6 039 561 | −0,13 | 180,54 | −1 376 076 | 1 090 382 343 |
2021-08-25 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −1 814 | 6 047 183 | −0,03 | 180,06 | −326 629 | 1 088 855 771 |
2021-08-25 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −1 482 | 6 048 997 | −0,02 | 180,22 | −267 086 | 1 090 150 239 |
2021-08-20 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −2 301 | 6 050 479 | −0,04 | 180,49 | −415 307 | 1 092 050 955 |
2021-08-18 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −5 246 | 6 052 780 | −0,09 | 182,10 | −955 297 | 1 102 211 238 |
2021-08-18 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −16 817 | 6 058 026 | −0,28 | 182,83 | −3 074 652 | 1 107 588 894 |
2021-08-09 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −556 | 6 074 843 | −0,01 | 180,04 | −100 102 | 1 093 714 734 |
2021-07-28 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −131 | 6 075 399 | 0,00 | 180,93 | −23 702 | 1 099 221 941 |
2021-07-28 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −15 209 | 6 075 530 | −0,25 | 181,47 | −2 759 977 | 1 102 526 429 |
2021-07-26 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −18 882 | 6 090 739 | −0,31 | 181,21 | −3 421 607 | 1 103 702 814 |
2021-07-26 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −8 516 | 6 109 621 | −0,14 | 180,63 | −1 538 245 | 1 103 580 841 |
2021-07-22 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −9 206 | 6 118 137 | −0,15 | 182,42 | −1 679 359 | 1 116 070 552 |
2021-07-22 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −10 176 | 6 127 343 | −0,17 | 183,06 | −1 862 819 | 1 121 671 410 |
2021-07-20 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −1 442 | 6 137 519 | −0,02 | 181,11 | −261 161 | 1 111 566 066 |
2021-07-20 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −12 454 | 6 138 961 | −0,20 | 182,83 | −2 276 965 | 1 122 386 240 |
2021-07-16 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −13 697 | 6 151 415 | −0,22 | 181,88 | −2 491 210 | 1 118 819 360 |
2021-07-16 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −11 026 | 6 165 112 | −0,18 | 182,63 | −2 013 678 | 1 125 934 405 |
2021-07-14 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −13 050 | 6 176 138 | −0,21 | 182,96 | −2 387 628 | 1 129 986 208 |
2021-07-14 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −10 540 | 6 189 188 | −0,17 | 183,22 | −1 931 139 | 1 133 983 025 |
2021-07-12 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −12 597 | 6 199 728 | −0,20 | 183,34 | −2 309 534 | 1 136 658 132 |
2021-07-12 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −3 951 | 6 212 325 | −0,06 | 180,18 | −711 891 | 1 119 336 718 |
2021-07-08 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −4 574 | 6 216 276 | −0,07 | 180,33 | −824 829 | 1 120 981 051 |
2021-07-08 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −4 729 | 6 220 850 | −0,08 | 180,58 | −853 963 | 1 123 361 093 |
2021-07-06 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −3 556 | 6 225 579 | −0,06 | 180,16 | −640 649 | 1 121 600 313 |
2021-07-06 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −238 | 6 229 135 | 0,00 | 180,03 | −42 847 | 1 121 431 174 |
2021-07-01 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −4 926 | 6 229 373 | −0,08 | 181,11 | −892 148 | 1 128 201 744 |
2021-06-29 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −8 225 | 6 234 299 | −0,13 | 181,15 | −1 489 959 | 1 129 343 264 |
2021-06-29 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −10 846 | 6 242 524 | −0,17 | 180,56 | −1 958 354 | 1 127 150 133 |
2021-06-25 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −1 837 | 6 253 370 | −0,03 | 180,79 | −332 111 | 1 130 546 762 |
2021-06-23 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −12 133 | 6 255 207 | −0,19 | 182,31 | −2 211 967 | 1 140 386 788 |
2021-06-23 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −9 345 | 6 267 340 | −0,15 | 181,86 | −1 699 482 | 1 139 778 452 |
2021-06-21 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −1 261 | 6 276 685 | −0,02 | 180,43 | −227 522 | 1 132 502 275 |
2021-06-21 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −8 927 | 6 277 946 | −0,14 | 181,20 | −1 617 572 | 1 137 563 815 |
2021-06-17 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −17 413 | 6 286 873 | −0,28 | 181,13 | −3 154 017 | 1 138 741 306 |
2021-06-17 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −15 706 | 6 304 286 | −0,25 | 182,00 | −2 858 492 | 1 147 380 052 |
2021-04-29 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 57 570 | 57 570 | |||||
2021-04-27 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −20 729 | 6 319 992 | −0,33 | 193,38 | −4 008 574 | 1 222 160 053 |
2021-04-27 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −7 805 | 6 340 721 | −0,12 | 190,51 | −1 486 931 | 1 207 970 758 |
2021-04-23 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −14 377 | 6 348 526 | −0,23 | 188,64 | −2 712 077 | 1 197 585 945 |
2021-04-23 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −15 687 | 6 362 903 | −0,25 | 187,02 | −2 933 783 | 1 189 990 119 |
2021-04-21 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −17 623 | 6 378 590 | −0,28 | 182,44 | −3 215 140 | 1 163 709 960 |
2021-04-21 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −8 471 | 6 396 213 | −0,13 | 180,90 | −1 532 404 | 1 157 074 932 |
2021-04-16 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −17 528 | 6 404 684 | −0,27 | 180,30 | −3 160 298 | 1 154 764 525 |
2021-04-16 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −31 270 | 6 422 212 | −0,48 | 186,65 | −5 836 546 | 1 198 705 870 |
2021-04-16 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −3 720 | 6 453 482 | −0,06 | 180,48 | −671 386 | 1 164 724 431 |
2021-01-11 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −26 666 | 6 457 202 | −0,41 | 140,71 | −3 752 173 | 908 592 893 |
2021-01-08 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −93 552 | 6 483 868 | −1,42 | 140,06 | −13 102 893 | 908 130 552 |
2021-01-08 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −91 667 | 6 577 420 | −1,37 | 140,06 | −12 838 880 | 921 233 445 |
2021-01-07 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −11 112 | 0 | −100,00 | ||||
2021-01-07 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −10 887 | 0 | −100,00 | ||||
2021-01-07 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −65 305 | 0 | −100,00 | ||||
2021-01-07 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −5 925 | 0 | −100,00 | ||||
2021-01-07 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −92 118 | 0 | −100,00 | ||||
2021-01-07 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
M - Exercise | 11 112 | 6 669 087 | 0,17 | 18,23 | 202 572 | 121 577 456 | |
2021-01-07 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
M - Exercise | 10 887 | 6 657 975 | 0,16 | 16,88 | 183 773 | 112 386 618 | |
2021-01-07 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
M - Exercise | 65 305 | 6 647 088 | 0,99 | 16,20 | 1 057 941 | 107 682 826 | |
2021-01-07 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
M - Exercise | 5 925 | 6 581 783 | 0,09 | 14,41 | 85 379 | 94 843 493 | |
2021-01-07 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
M - Exercise | 92 118 | 6 575 858 | 1,42 | 14,41 | 1 327 420 | 94 758 114 | |
2021-01-06 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −10 127 | 6 483 740 | −0,16 | 140,01 | −1 417 881 | 907 788 437 |
2020-12-31 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −19 930 | 6 493 867 | −0,31 | 140,01 | −2 790 399 | 909 206 319 |
2020-12-29 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −1 374 | 6 513 797 | −0,02 | 140,00 | −192 360 | 911 931 580 |
2020-12-29 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −3 829 | 6 515 171 | −0,06 | 140,00 | −536 060 | 912 123 940 |
2020-12-29 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −40 000 | 37 417 | −51,67 | ||||
2020-12-29 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
M - Exercise | 40 000 | 706 643 | 6,00 | 54,74 | 2 189 600 | 38 681 638 | |
2020-12-29 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −3 547 | 6 519 000 | −0,05 | 140,11 | −496 970 | 913 377 090 |
2020-12-23 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −33 260 | 6 522 547 | −0,51 | 140,01 | −4 656 733 | 913 221 805 |
2020-12-18 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −216 048 | 6 555 807 | −3,19 | 141,85 | −30 646 409 | 929 941 223 |
2020-12-03 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −14 000 | 6 771 855 | −0,21 | 130,86 | −1 832 040 | 886 164 945 |
2020-10-07 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −50 000 | 0 | −100,00 | ||||
2020-10-07 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
M - Exercise | 50 000 | 666 643 | 8,11 | 23,00 | 1 150 000 | 15 332 789 | |
2020-10-07 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −2 592 | 65 305 | −3,82 | ||||
2020-10-07 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −1 851 | 92 118 | −1,97 | ||||
2020-10-07 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
M - Exercise | 2 592 | 6 785 855 | 0,04 | 16,20 | 41 990 | 109 930 851 | |
2020-10-07 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
M - Exercise | 1 851 | 6 783 263 | 0,03 | 14,41 | 26 673 | 97 746 820 | |
2020-09-02 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
J - Other | −9 354 | 6 781 412 | −0,14 | ||||
2020-08-28 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −2 034 | 6 790 766 | −0,03 | 121,94 | −248 026 | 828 066 006 |
2020-08-28 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −13 889 | 6 792 800 | −0,20 | 123,53 | −1 715 708 | 839 114 584 |
2020-08-26 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −11 597 | 6 806 689 | −0,17 | 123,23 | −1 429 098 | 838 788 285 |
2020-08-26 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −18 903 | 6 818 286 | −0,28 | 123,36 | −2 331 874 | 841 103 761 |
2020-08-24 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −24 304 | 6 837 189 | −0,35 | 124,37 | −3 022 688 | 850 341 196 |
2020-08-24 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −18 813 | 6 861 493 | −0,27 | 125,83 | −2 367 240 | 863 381 664 |
2020-08-20 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −21 614 | 6 880 306 | −0,31 | 127,63 | −2 758 595 | 878 133 455 |
2020-08-20 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −16 589 | 6 901 920 | −0,24 | 127,26 | −2 111 116 | 878 338 339 |
2020-08-18 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −16 485 | 6 918 509 | −0,24 | 128,18 | −2 113 047 | 886 814 484 |
2020-08-18 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −16 857 | 6 934 994 | −0,24 | 127,07 | −2 142 019 | 881 229 688 |
2020-08-14 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −16 671 | 6 951 851 | −0,24 | 127,87 | −2 131 721 | 888 933 187 |
2020-08-14 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −21 916 | 6 968 522 | −0,31 | 127,21 | −2 787 934 | 886 465 684 |
2020-08-12 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −38 642 | 6 990 438 | −0,55 | 125,30 | −4 841 843 | 875 901 881 |
2020-08-12 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −48 148 | 7 029 080 | −0,68 | 120,79 | −5 815 797 | 849 042 573 |
2020-08-10 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −19 942 | 7 077 228 | −0,28 | 123,63 | −2 465 429 | 874 957 698 |
2020-08-10 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −15 033 | 7 097 170 | −0,21 | 122,43 | −1 840 490 | 868 906 523 |
2020-08-06 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −13 179 | 7 112 203 | −0,18 | 125,04 | −1 647 902 | 889 309 863 |
2020-08-06 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −45 488 | 7 125 382 | −0,63 | 124,43 | −5 660 072 | 886 611 282 |
2020-08-04 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −27 005 | 7 170 870 | −0,38 | 124,13 | −3 352 131 | 890 120 093 |
2020-08-04 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −39 622 | 7 197 875 | −0,55 | 118,17 | −4 682 132 | 850 572 889 |
2020-07-31 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −42 955 | 7 237 497 | −0,59 | 120,79 | −5 188 534 | 874 217 263 |
2020-07-31 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −47 106 | 7 280 452 | −0,64 | 123,99 | −5 840 673 | 902 703 243 |
2020-07-29 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −214 499 | 7 327 558 | −2,84 | 127,23 | −27 290 708 | 932 285 204 |
2020-07-29 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −29 019 | 7 542 057 | −0,38 | 110,43 | −3 204 568 | 832 869 355 |
2020-07-27 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −34 380 | 7 571 076 | −0,45 | 106,13 | −3 648 749 | 803 518 296 |
2020-07-27 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −31 743 | 7 605 456 | −0,42 | 111,83 | −3 549 820 | 850 518 144 |
2020-07-23 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −35 878 | 7 637 199 | −0,47 | 109,99 | −3 946 221 | 840 015 518 |
2020-07-23 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −28 090 | 7 673 077 | −0,36 | 106,78 | −2 999 450 | 819 331 162 |
2020-07-21 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −17 735 | 7 701 167 | −0,23 | 105,47 | −1 870 510 | 812 242 083 |
2020-07-21 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −19 309 | 7 718 902 | −0,25 | 105,32 | −2 033 624 | 812 954 759 |
2020-07-17 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −15 273 | 7 738 211 | −0,20 | 103,70 | −1 583 810 | 802 452 481 |
2020-07-17 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −28 700 | 7 753 484 | −0,37 | 104,90 | −3 010 630 | 813 340 472 |
2020-07-13 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −6 127 | 7 782 184 | −0,08 | 100,50 | −615 764 | 782 109 492 |
2020-07-13 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −2 455 | 7 788 311 | −0,03 | 100,15 | −245 868 | 779 999 347 |
2020-05-08 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −3 518 | 93 969 | −3,61 | ||||
2020-05-08 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
M - Exercise | 3 518 | 7 790 766 | 0,05 | 14,41 | 50 694 | 112 264 938 | |
2020-03-03 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 84 770 | 84 770 | |||||
2020-03-03 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
A - Award | 12 941 | 616 643 | 2,14 | ||||
2020-02-04 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −2 962 | 67 897 | −4,18 | ||||
2020-02-04 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −8 888 | 5 925 | −60,00 | ||||
2020-02-04 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −14 814 | 97 487 | −13,19 | ||||
2020-02-04 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
M - Exercise | 2 962 | 7 787 248 | 0,04 | 16,20 | 47 984 | 126 153 418 | |
2020-02-04 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
M - Exercise | 8 888 | 7 784 286 | 0,11 | 14,41 | 128 076 | 112 171 561 | |
2020-02-04 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
M - Exercise | 14 814 | 7 775 398 | 0,19 | 14,41 | 213 470 | 112 043 485 | |
2019-11-19 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −555 | 70 859 | −0,78 | ||||
2019-11-19 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −518 | 112 301 | −0,46 | ||||
2019-11-19 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
M - Exercise | 555 | 7 760 584 | 0,01 | 16,20 | 8 991 | 125 721 461 | |
2019-11-19 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
M - Exercise | 518 | 7 760 029 | 0,01 | 14,41 | 7 464 | 111 822 018 | |
2019-11-19 |
|
4/A | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −1 851 | 71 414 | −2,53 | ||||
2019-11-19 |
|
4/A | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −2 222 | 14 813 | −13,04 | ||||
2019-11-19 |
|
4/A | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −4 313 | 112 819 | −3,68 | ||||
2019-09-26 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | 1 851 | 71 414 | 2,66 | ||||
2019-09-26 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | 2 222 | 14 813 | 17,65 | ||||
2019-09-26 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | 4 313 | 112 819 | 3,97 | ||||
2019-09-26 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
M - Exercise | 1 851 | 7 759 511 | 0,02 | 16,20 | 29 986 | 125 704 078 | |
2019-09-26 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
M - Exercise | 2 222 | 7 757 660 | 0,03 | 14,41 | 32 019 | 111 787 881 | |
2019-09-26 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
M - Exercise | 4 313 | 7 755 438 | 0,06 | 14,41 | 62 150 | 111 755 862 | |
2019-09-17 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
P - Purchase | 11 112 | 11 112 | 36,77 | 408 588 | 408 588 | ||
2019-09-17 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
P - Purchase | 10 887 | 10 887 | 38,12 | 415 012 | 415 012 | ||
2019-09-17 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
P - Purchase | 73 265 | 73 265 | 38,80 | 2 842 682 | 2 842 682 | ||
2019-09-17 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
P - Purchase | 17 035 | 17 035 | 40,59 | 691 451 | 691 451 | ||
2019-09-17 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
P - Purchase | 117 132 | 117 132 | 40,59 | 4 754 388 | 4 754 388 | ||
2019-08-07 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 100 000 | 100 000 | |||||
2019-05-06 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 234 259 | 234 259 | |||||
2019-03-05 |
|
4 | MEDP |
Medpace Holdings, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 77 417 | 77 417 | |||||
2019-02-05 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −18 920 | 7 751 125 | −0,24 | 66,54 | −1 258 937 | 515 759 858 |
2019-02-05 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −84 093 | 7 770 045 | −1,07 | 65,54 | −5 511 455 | 509 248 749 |
2019-01-31 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −68 383 | 7 854 138 | −0,86 | 64,19 | −4 389 505 | 504 157 118 |
2019-01-31 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −102 828 | 7 922 521 | −1,28 | 63,22 | −6 500 786 | 500 861 778 |
2019-01-31 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −1 100 | 8 025 349 | −0,01 | 61,05 | −67 155 | 489 947 556 |
2019-01-28 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −4 221 | 8 026 449 | −0,05 | 61,04 | −257 650 | 489 934 447 |
2019-01-28 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −27 958 | 8 030 670 | −0,35 | 61,13 | −1 709 073 | 490 914 857 |
2019-01-28 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −3 501 | 8 058 628 | −0,04 | 61,14 | −214 051 | 492 704 516 |
2019-01-23 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −24 160 | 8 062 129 | −0,30 | 61,22 | −1 479 075 | 493 563 537 |
2019-01-23 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −9 936 | 8 086 289 | −0,12 | 61,10 | −607 090 | 494 072 258 |
2019-01-23 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −38 318 | 8 096 225 | −0,47 | 61,43 | −2 353 875 | 497 351 102 |
2019-01-23 |
|
4/A | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −8 760 | 8 134 543 | −0,11 | 61,17 | −535 849 | 497 589 995 |
2019-01-23 |
|
4/A | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −7 222 | 8 143 303 | −0,09 | 61,57 | −444 659 | 501 383 166 |
2019-01-23 |
|
4/A | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −600 | 8 150 525 | −0,01 | 61,00 | −36 600 | 497 182 025 |
2019-01-17 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −8 760 | 8 134 543 | −0,11 | 61,17 | −535 849 | 497 589 995 |
2019-01-17 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −7 222 | 8 143 303 | −0,09 | 61,57 | −444 659 | 501 383 166 |
2019-01-17 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −600 | 8 150 525 | −0,01 | 61,00 | −36 600 | 497 182 025 |
2018-10-11 |
|
4/A | MEDP |
Medpace Holdings, Inc.
Common Stock |
J - Other | −744 385 | 8 151 125 | −8,37 | 59,91 | −44 596 105 | 488 333 899 | |
2018-10-02 |
|
4/A | MEDP |
Medpace Holdings, Inc.
Common Stock |
J - Other | −747 454 | 8 148 056 | −8,40 | 59,91 | −44 779 969 | 488 150 035 | |
2018-10-01 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
J - Other | 251 851 | 603 702 | 71,58 | 59,91 | 15 088 393 | 36 167 787 | |
2018-10-01 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
J - Other | −748 459 | 8 147 051 | −8,41 | 59,91 | −44 840 179 | 488 089 825 | |
2018-09-27 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −46 778 | 8 895 510 | −0,52 | 58,96 | −2 758 031 | 524 479 270 |
2018-09-27 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −46 886 | 8 942 288 | −0,52 | 58,38 | −2 737 205 | 522 050 773 |
2018-09-27 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −38 640 | 8 989 174 | −0,43 | 58,36 | −2 255 030 | 524 608 195 |
2018-09-24 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −2 713 | 9 027 814 | −0,03 | 58,47 | −158 629 | 527 856 285 |
2018-09-21 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −53 842 | 9 030 527 | −0,59 | 58,29 | −3 138 450 | 526 389 419 |
2018-09-21 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −61 141 | 9 084 369 | −0,67 | 60,20 | −3 680 688 | 546 879 014 |
2018-08-09 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −138 105 | 351 851 | −28,19 | 57,06 | −7 880 271 | 20 076 618 |
2018-08-09 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
J - Other | −37 037 | 9 145 510 | −0,40 | ||||
2018-08-09 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
J - Other | −27 571 | 9 182 547 | −0,30 | ||||
2018-08-06 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −156 369 | 489 956 | −24,19 | 58,51 | −9 149 150 | 28 667 326 |
2018-08-06 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −203 296 | 646 325 | −23,93 | 59,94 | −12 185 562 | 38 740 720 |
2018-08-06 |
|
4 | MEDP |
Medpace Holdings, Inc.
Common Stock |
S - Sale | X | −371 795 | 849 621 | −30,44 | 59,20 | −22 010 264 | 50 297 563 |
2018-02-05 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Stock Option (Right to Buy) |
A - Award | 20 000 | 20 000 | |||||
2017-05-19 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Stock Option (Right to Buy) |
A - Award | 20 000 | 20 000 | |||||
2016-08-19 |
|
4 | MEDP |
Medpace Holdings, Inc.
COMMON STOCK |
P - Purchase | 10 000 | 10 000 | 27,98 | 279 800 | 279 800 | ||
2016-08-17 |
|
4 | MEDP |
Medpace Holdings, Inc.
COMMON STOCK |
P - Purchase | 869 565 | 1 221 416 | 247,14 | 23,00 | 19 999 995 | 28 092 568 | |
2016-08-12 |
|
4 | MEDP |
Medpace Holdings, Inc.
EMPLOYEE STOCK OPTION (RIGHT TO BUY) |
A - Award | 50 000 | 50 000 | |||||
2016-08-10 | 3 | MEDP |
Medpace Holdings, Inc.
Common Stock |
9 913 820 | ||||||||
2016-08-10 | 3 | MEDP |
Medpace Holdings, Inc.
Common Stock |
18 772 087 | ||||||||
2016-08-10 | 3 | MEDP |
Medpace Holdings, Inc.
Common Stock |
9 913 820 | ||||||||
2016-08-10 | 3 | MEDP |
Medpace Holdings, Inc.
Common Stock |
18 772 087 | ||||||||
2016-05-26 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Stock Option (Right to Buy) |
A - Award | 10 000 | 10 000 | |||||
2016-03-11 |
|
4 | CHRS |
Coherus BioSciences, Inc.
8.2% Senior Convertible Notes due 2022 |
P - Purchase | 22,35 | ||||||
2016-02-11 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Stock Option (Right to Buy) |
M - Exercise | −8 124 | 0 | −100,00 | ||||
2016-02-11 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Common Stock, $0.0001 par value |
M - Exercise | 8 124 | 29 994 | 37,15 | 0,42 | 3 386 | 12 501 | |
2015-08-03 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Common Stock, $0.0001 par value |
S - Sale | X | −860 | 268 428 | −0,32 | 35,15 | −30 233 | 9 436 425 |
2015-08-03 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Common Stock, $0.0001 par value |
S - Sale | X | −24 809 | 269 288 | −8,44 | 34,09 | −845 729 | 9 179 920 |
2015-08-03 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Common Stock, $0.0001 par value |
S - Sale | X | −62 442 | 294 097 | −17,51 | 33,77 | −2 108 492 | 9 930 832 |
2015-08-03 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Common Stock, $0.0001 par value |
S - Sale | X | −1 889 | 356 539 | −0,53 | 32,22 | −60 872 | 11 489 255 |
2015-08-03 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Common Stock, $0.0001 par value |
S - Sale | X | −2 370 | 1 642 492 | −0,14 | 35,15 | −83 315 | 57 740 000 |
2015-08-03 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Common Stock, $0.0001 par value |
S - Sale | X | −68 941 | 1 644 862 | −4,02 | 34,09 | −2 350 178 | 56 072 852 |
2015-08-03 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Common Stock, $0.0001 par value |
S - Sale | X | −173 440 | 1 713 803 | −9,19 | 33,77 | −5 856 601 | 57 870 500 |
2015-08-03 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Common Stock, $0.0001 par value |
S - Sale | X | −5 249 | 1 887 243 | −0,28 | 32,22 | −169 145 | 60 815 085 |
2015-06-16 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Common Stock, $0.0001 par value |
S - Sale | −2 376 | 1 892 492 | −0,13 | 27,08 | −64 331 | 51 239 789 | |
2015-06-16 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Common Stock, $0.0001 par value |
S - Sale | −111 606 | 1 894 868 | −5,56 | 26,62 | −2 970 583 | 50 435 133 | |
2015-06-16 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Common Stock, $0.0001 par value |
S - Sale | −1 851 | 2 006 474 | −0,09 | 27,29 | −50 512 | 54 755 271 | |
2015-06-16 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Common Stock, $0.0001 par value |
S - Sale | −134 167 | 2 008 325 | −6,26 | 26,72 | −3 585 251 | 53 667 063 | |
2015-05-27 |
|
4/A | CHRS |
Coherus BioSciences, Inc.
Stock Option (Right to Buy) |
A - Award | 20 000 | 20 000 | |||||
2015-04-03 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Stock Option (Right to Buy) |
A - Award | 20 000 | 20 000 | |||||
2014-11-12 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Series B Preferred Stock |
C - Conversion | −358 428 | 0 | −100,00 | ||||
2014-11-12 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Series C Preferred Stock |
C - Conversion | −266 502 | 0 | −100,00 | ||||
2014-11-12 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Series B Preferred Stock |
C - Conversion | −1 556 055 | 0 | −100,00 | ||||
2014-11-12 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Series A Preferred Stock |
C - Conversion | −319 935 | 0 | −100,00 | ||||
2014-11-12 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Series B Preferred Stock |
X - Other | 107 528 | 1 556 055 | 7,42 | 0,02 | 1 796 | 25 986 | |
2014-11-12 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Warrant to Purchase Series B Preferred Stock |
X - Other | −107 528 | 0 | −100,00 | ||||
2014-11-12 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Common Stock, $0.0001 par value |
C - Conversion | 358 428 | 358 428 | |||||
2014-11-12 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Common Stock, $0.0001 par value |
C - Conversion | 266 502 | 2 142 492 | 14,21 | ||||
2014-11-12 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Common Stock, $0.0001 par value |
C - Conversion | 1 556 055 | 1 875 990 | 486,37 | ||||
2014-11-12 |
|
4 | CHRS |
Coherus BioSciences, Inc.
Common Stock, $0.0001 par value |
C - Conversion | 319 935 | 319 935 | |||||
2014-11-06 | 3 | CHRS |
Coherus BioSciences, Inc.
Common Stock, $0.0001 par value |
43 740 | ||||||||
2014-11-06 | 3 | CHRS |
Coherus BioSciences, Inc.
Common Stock, $0.0001 par value |
43 740 |